CRISPR & Cas Genes Market Research Report by Component (Product and Service), Application, End-user, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030- Product Image

Sale

CRISPR & Cas Genes Market Research Report by Component (Product and Service), Application, End-user, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Report
257 Pages
January 2023
Region: Global
360iResearch™
ID: 5336284

UP TO €855EUR$895USD£754GBP OFF until Mar 31^st 2023

The Global CRISPR & Cas Genes Market size was estimated at USD 2,883.43 million in 2022, USD 3,813.43 million in 2023, and is projected to grow at a CAGR of 32.38% to reach USD 27,211.27 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global CRISPR & Cas Genes Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global CRISPR & Cas Genes Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global CRISPR & Cas Genes Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global CRISPR & Cas Genes Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global CRISPR & Cas Genes Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Component, the market is studied across Product and Service. The Product is further studied across Antibodies, Design Tool, Kits & Enzymes, and Libraries. The Kits & Enzymes is further studied across DNA-Free Cas and Vector-Based Cas. The Service is further studied across Cell Line Engineering, DNA Synthesis, gRNA Design, and Microbial Gene Editing.
Based on Application, the market is studied across Agricultural and Biomedical. The Biomedical is further studied across Disease Model Studies, Epigenetics, Functional Genomics, and Genome Engineering.
Based on End-user, the market is studied across Academics & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global CRISPR & Cas Genes Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global CRISPR & Cas Genes Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global CRISPR & Cas Genes Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global CRISPR & Cas Genes Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global CRISPR & Cas Genes Market, including AstraZeneca plc, Beam Therapeutics Inc., Beckman Coulter, Inc., Calyxt, Inc., Caribou Biosciences, Inc., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., Hera Biolabs, Horizon Discovery Group Plc, Inscripta, Inc., Integrated Dna Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group, and Mammoth Biosciences.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global CRISPR & Cas Genes Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global CRISPR & Cas Genes Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global CRISPR & Cas Genes Market?
4. What is the competitive strategic window for opportunities in the Global CRISPR & Cas Genes Market?
5. What are the technology trends and regulatory frameworks in the Global CRISPR & Cas Genes Market?
6. What is the market share of the leading vendors in the Global CRISPR & Cas Genes Market?
7. What modes and strategic moves are considered suitable for entering the Global CRISPR & Cas Genes Market?

Frequently Asked Questions about the Global CRISPR & Cas Genes Market

What is the estimated value of the Global CRISPR & Cas Genes Market?

The Global CRISPR & Cas Genes Market was estimated to be valued at $2883.43 Million in 2022.

What is the growth rate of the Global CRISPR & Cas Genes Market?

The growth rate of the Global CRISPR & Cas Genes Market is 32.3%, with an estimated value of $27211.27 Million by 2030.

What is the forecasted size of the Global CRISPR & Cas Genes Market?

The Global CRISPR & Cas Genes Market is estimated to be worth $27211.27 Million by 2030.

Who are the key companies in the Global CRISPR & Cas Genes Market?

Key companies in the Global CRISPR & Cas Genes Market include AstraZeneca plc, Beam Therapeutics Inc., Beckman Coulter, Inc., Calyxt, Inc., Caribou Biosciences, Inc., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc. and Horizon Discovery Group Plc.

Report Attribute	Details
No. of Pages	257
Published	January 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 2883.43 Million
Forecasted Market Value ( USD ) by 2030	$ 27211.27 Million
Compound Annual Growth Rate	32.3%
Regions Covered	Global
No. of Companies Mentioned	15

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Development of CRISPR-based diagnostic assays for sample tissue screening
5.1.1.2. High prevalence of genetic disorders
5.1.1.3. Rising application in drug discovery, biomedical research, and non-transgenic bleeding
5.1.2. Restraints
5.1.2.1. Off-target effects of CRISPR technology
5.1.3. Opportunities
5.1.3.1. Evolution of anti-CRISPR protein
5.1.3.2. Research and development for novel application of CRISPR-Cas genes
5.1.4. Challenges
5.1.4.1. Patent landscape and dispute
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. CRISPR & Cas Genes Market, by Component
6.1. Introduction
6.2. Product
6.3.1. Antibodies
6.3.2. Design Tool
6.3.3. Kits & Enzymes
6.3.4.1. DNA-Free Cas
6.3.4.2. Vector-Based Cas
6.3.4. Libraries
6.3. Service
6.4.1. Cell Line Engineering
6.4.2. DNA Synthesis
6.4.3. gRNA Design
6.4.4. Microbial Gene Editing

7. CRISPR & Cas Genes Market, by Application
7.1. Introduction
7.2. Agricultural
7.3. Biomedical
7.4.1. Disease Model Studies
7.4.2. Epigenetics
7.4.3. Functional Genomics
7.4.4. Genome Engineering

8. CRISPR & Cas Genes Market, by End-user
8.1. Introduction
8.2. Academics & Government Research Institutes
8.3. Biotechnology & Pharmaceutical Companies
8.4. Contract Research Organizations

9. Americas CRISPR & Cas Genes Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific CRISPR & Cas Genes Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa CRISPR & Cas Genes Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AstraZeneca plc
13.2. Beam Therapeutics Inc.
13.3. Beckman Coulter, Inc.
13.4. Calyxt, Inc.
13.5. Caribou Biosciences, Inc.
13.6. CRISPR Therapeutics AG
13.7. Danaher Corporation
13.8. Editas Medicine, Inc.
13.9. Hera Biolabs
13.10. Horizon Discovery Group Plc
13.11. Inscripta, Inc.
13.12. Integrated Dna Technologies, Inc.
13.13. Intellia Therapeutics, Inc.
13.14. Lonza Group
13.15. Mammoth Biosciences

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL CRISPR & CAS GENES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CRISPR & CAS GENES MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CRISPR & CAS GENES MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRISPR & CAS GENES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL CRISPR & CAS GENES MARKET DYNAMICS
FIGURE 11. GLOBAL CRISPR & CAS GENES MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
FIGURE 13. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CRISPR & CAS GENES MARKET COMPETITIVE STRATEGIC WINDOW, BY COMPONENT, 2030
FIGURE 15. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DESIGN TOOL, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
FIGURE 19. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DNA-FREE CAS, 2018-2030 (USD MILLION)
FIGURE 20. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY VECTOR-BASED CAS, 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LIBRARIES, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CELL LINE ENGINEERING, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
FIGURE 25. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GRNA DESIGN, 2018-2030 (USD MILLION)
FIGURE 26. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY MICROBIAL GENE EDITING, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 28. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 29. GLOBAL CRISPR & CAS GENES MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 30. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
FIGURE 31. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
FIGURE 32. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DISEASE MODEL STUDIES, 2018-2030 (USD MILLION)
FIGURE 33. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY EPIGENETICS, 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
FIGURE 35. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENOME ENGINEERING, 2018-2030 (USD MILLION)
FIGURE 36. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 37. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 38. GLOBAL CRISPR & CAS GENES MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 39. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
FIGURE 40. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
FIGURE 41. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
FIGURE 42. AMERICAS CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 44. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 45. AMERICAS CRISPR & CAS GENES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 46. ARGENTINA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. BRAZIL CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. CANADA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. MEXICO CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. UNITED STATES CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 52. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 53. UNITED STATES CRISPR & CAS GENES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 54. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 56. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 57. ASIA-PACIFIC CRISPR & CAS GENES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 58. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. CHINA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. INDIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. INDONESIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. JAPAN CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. MALAYSIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. SINGAPORE CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. TAIWAN CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. THAILAND CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. VIETNAM CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 74. DENMARK CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. EGYPT CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. FINLAND CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. FRANCE CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. GERMANY CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. ISRAEL CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. ITALY CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. NIGERIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. NORWAY CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. POLAND CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. QATAR CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 86. RUSSIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 87. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 89. SPAIN CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 90. SWEDEN CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 91. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 92. TURKEY CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 93. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 94. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 95. GLOBAL CRISPR & CAS GENES MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 96. GLOBAL CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 97. GLOBAL CRISPR & CAS GENES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022List of Tables
TABLE 1. GLOBAL CRISPR & CAS GENES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DESIGN TOOL, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DESIGN TOOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DESIGN TOOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DNA-FREE CAS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DNA-FREE CAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DNA-FREE CAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY VECTOR-BASED CAS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY VECTOR-BASED CAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY VECTOR-BASED CAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LIBRARIES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LIBRARIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LIBRARIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CELL LINE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GRNA DESIGN, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GRNA DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GRNA DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY MICROBIAL GENE EDITING, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY MICROBIAL GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY MICROBIAL GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DISEASE MODEL STUDIES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DISEASE MODEL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DISEASE MODEL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY EPIGENETICS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENOME ENGINEERING, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENOME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENOME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. CANADA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 86. CANADA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 87. CANADA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CANADA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. CHINA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 108. CHINA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 109. CHINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. CHINA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. INDIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 112. INDIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 113. INDIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. INDIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. JAPAN CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 120. JAPAN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 121. JAPAN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. JAPAN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SINGAPORE CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 132. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 136. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 137. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. THAILAND CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 144. THAILAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 145. THAILAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. THAILAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. DENMARK CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 157. DENMARK CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 158. DENMARK CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. DENMARK CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. EGYPT CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 161. EGYPT CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 162. EGYPT CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. EGYPT CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. FINLAND CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 165. FINLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 166. FINLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. FINLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. FRANCE CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 169. FRANCE CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 170. FRANCE CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. FRANCE CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. GERMANY CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 173. GERMANY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 174. GERMANY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. GERMANY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. ITALY CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 181. ITALY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 182. ITALY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. ITALY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. NORWAY CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 193. NORWAY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 194. NORWAY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. NORWAY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. POLAND CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 197. POLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 198. POLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. POLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. QATAR CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 201. QATAR CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 202. QATAR CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. QATAR CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. SPAIN CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 217. SPAIN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 218. SPAIN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. SPAIN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. GLOBAL CRISPR & CAS GENES MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 241. GLOBAL CRISPR & CAS GENES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 242. GLOBAL CRISPR & CAS GENES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 243. GLOBAL CRISPR & CAS GENES MARKET RANKING, BY KEY PLAYER, 2022
TABLE 244. GLOBAL CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 245. GLOBAL CRISPR & CAS GENES MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 246. GLOBAL CRISPR & CAS GENES MARKET MERGER & ACQUISITION
TABLE 247. GLOBAL CRISPR & CAS GENES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 248. GLOBAL CRISPR & CAS GENES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 249. GLOBAL CRISPR & CAS GENES MARKET INVESTMENT & FUNDING
TABLE 250. GLOBAL CRISPR & CAS GENES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 251. GLOBAL CRISPR & CAS GENES MARKET: LICENSE & PRICING